There's currently no cure for #cysticfibrosis, but we're working to change that. Stars from @FiveFeetApart, including @colesprouse and Haley Lu Richardson, share how you can join the fight against CF. #CFawareness
The approval of the triple-combination modulator represents a truly transformational milestone in the fight against #cysticfibrosis. We could not be more excited about this pivotal moment in the history of CF.
FDA has approved a breakthrough triple combination therapy for patients 12 & older with the most common cystic fibrosis mutation, estimated at 90% of the cystic fibrosis patient population. go.usa.gov/xp3Cg
Congrats to @God_Son80 for being selected as the @Browns 2019 Walter Payton Man of the Year nominee! Whether he’s on the field wearing custom cleats, or off the field hosting a fundraiser, we’re grateful for his efforts to add tomorrows for the CF community. #WPMOYChallengeLandry
We couldn’t be more grateful for the support of @Browns wide receiver @God_Son80 on and off the field. Now let’s show him our support in the Walter Payton NFL Man of the Year challenge!
Retweet this post with #WPMOYChallenge + Landry. Every RT is another vote!
“This is a moment to celebrate and to reflect on how working together, and against great odds, we have effectively transformed a genetic disease in a single generation, making #cysticfibrosis the greatest story in medicine" - Dr. Michael Boyle on.cff.org/33T80Im
Congratulations to @colesprouse for winning the Drama Movie Star of 2019 at the #PCAs for his role in @FiveFeetApart! Watch his acceptance speech to hear his take on how the movie raised #CFawareness.
Today, the U.S. FDA approved the triple-combination modulator elexacaftor/ivacaftor/tezacaftor (Trikafta™) for people with #cysticfibrosis 12 years and older who have at least one F508del mutation. on.cff.org/31vq0a9
With $500,000,000 in funding, the Foundation is setting out the Path to a Cure – an ambitious research agenda – and challenging industry to develop treatments for the underlying cause of disease for all people with #cysticfibrosis. on.cff.org/2Jyk3Dk
Today we celebrate the 1️⃣ year anniversary of the approval of Trikafta, a CFTR modulator for people with cystic fibrosis ages 12 and older with at least one F508del mutation.
As we celebrate, let's look back on the reflections of the CF community from the last year. 🧵
ALT A light-skinned man wearing a blue LA Rams t-shirt and a backward baseball cap smiles at the camera as he holds up two custom-designed cleats in his hands. In his right hand is a purple cleat with painted pink lungs and a purple awareness ribbon. In his left hand is a teal cleat that reads, "Cystic Fibrosis Foundation. The bottom of the graphic reads, "42, Matthew Orzech, Cystic Fibrosis Foundation, My Cause My Cleats.
ALT Images shows two cleats, on the left is a purple cleat with painted pink lungs and a purple awareness ribbon. On the right is a teal cleat that reads, "Cystic Fibrosis Foundation.
The @US_FDA approved Trikafta for children with CF ages 2-5 years with at least one copy of the F508del mutation or one copy of certain mutations. With this approval, more than 900 children will have access to a CFTR modulator for the first time. cff.org/news/2023-04/trikaft…
According to 2023 Patient Registry data, the median predicted age of survival for people with cystic fibrosis born between 2019-2023 is 61. Let’s break down what this number means.
Congratulations to Lauren Luteran, a 19-year-old contemporary dancer living with #cysticfibrosis, who received a ticket to the academy after her performance last night on @DANCEonFOX! 💃
The @US_FDA has approved the use of Trikafta for children with CF ages 6 - 11 who have at least one copy of the F508del mutation or one copy of certain mutations. With this approval, about 1,500 children are eligible for a modulator for the first time. on.cff.org/2RD5gOV
The @US_FDA has approved a new drug that treats the underlying cause of #cysticfibrosis, Symdeko (tezacaftor/ivacaftor and ivacaftor). More to come. #CFresearch
“CF was once a disease without hope. CF is not only the most amazing story in medicine, but because of your work, hope now abounds. We need to finish and finishing means curing #cysticfibrosis for everyone. We won’t leave anyone behind.” - Preston W. Campbell, III, MD #NACFC
Congratulations to Brianna Collichio, a 15-year-old singer with cystic fibrosis, who received a golden ticket on #AmericanIdol last night! on.cff.org/3tmSIbS
Hi, Kim! If you like the movie, we'd encourage you to check out our website to learn more about the realities of life with #cysticfibrosis. on.cff.org/fivefeetapart
“The number of people with CF who need a lung transplant continues to decrease with only 32 lung transplants for people with CF in 2022 and very few on the wait list. Prior to 2019, about 250 individuals received a lung transplant each year on average.” – Whitney Brown, MD
Vertex announced today that it will seek @US_FDA approval for its CFTR modulator VX-445 combined with tezacaftor/ivacaftor in the third quarter.
If approved, the drug could eventually benefit more than 90% of people with #cysticfibrosis. #CFresearchon.cff.org/30Wrtan
May is Cystic Fibrosis Awareness Month! Follow along all this month to learn how you can get involved and make a difference for everyone living with #cysticfibrosis. #CFawareness
Three years ago today, Trikafta®, a CFTR modulator that treats the underlying cause of CF, was approved. Since then, we've seen incredible progress, including an increase in pregnancies reported in the CF Patient Registry, fewer pulmonary exacerbations, and so much more.
Vertex announced positive Phase 3 clinical trial data for Trikafta in children 6 - 11 years old with #cysticfibrosis. Based on the results, Vertex plans to submit a supplemental New Drug Application to the @US_FDA in the fourth quarter of 2020. #CFresearchon.cff.org/339iTqI
Today, Vertex released positive results from two ongoing, late-stage clinical trials for the potential VX-445 triple combination therapy. #CFresearchon.cff.org/2ECh0XB
Exciting news for the #cysticfibrosis community! Today, the @US_FDA approved lumacaftor/ivacaftor (Orkambi) for children living with CF ages 2 to 5 who have two copies of the most common CF gene mutation, F508del. #CFresearchon.cff.org/2MsKkm3
The Path to a Cure will accelerate treatments for the underlying cause of #cysticfibrosis for everyone with the disease. Follow the path to learn what that could look like for you or your loved one with CF.
May is Cystic Fibrosis Awareness Month!
This is your month to shout a little louder about your CF story, and educate others about the realities of life with a rare disease. #CFAwareness
"We anticipate potential approval of a triple-combination therapy for people with #cysticfibrosis in 2020. This approval could over time lead to more than 90% of people with CF having highly effective treatments for the underlying cause of their disease." -Mike Boyle #CFFVLC
Happy birthday to Dorothy Andersen, MD! Dr. Andersen was the first person to identify #cysticfibrosis in 1938, changing the lives of thousands of people in the process.
ALT A light-skinned woman wearing a white lab coat sits and holds papers in her hand.
Ten years ago today, the @US_FDA approved Kalydeco, the first drug to treat the underlying cause of cystic fibrosis. It represented a major advance in our search for a cure for CF.
Getting a lung transplant is an incredibly complicated procedure and requires a large team to make sure the operation is successful. On #TransplantNursesDay, we thank all of the amazing transplant nurses who provide care to people with #cysticfibrosis every day.
Promising Phase 2 clinical trial results released for a potential mucus clearance drug from Spyryx Biosciences Inc. People living with #cysticfibrosis who inhaled the drug showed a 5.2% increase in FEV1 after 28 days. #CFresearchon.cff.org/2HtdNsC
Do you find it hard to explain #cysticfibrosis to your family and friends? Watch and share this video to see how lungs normally work, and how CF can affect the lungs over time. #CFawareness
The Foundation urges the Biden administration to consider top public health priorities for the #cysticfibrosis community, including early access to #COVID19 vaccines, telehealth, and paid leave, when developing their policy priorities. #CFadvocacyon.cff.org/presidentelectlet…
What better way to express your ❤️ than by being an organ donor? Watch Jennifer, an adult living with #cysticfibrosis, take her first breath following a double-lung transplant, and register to #DonateLife today: on.cff.org/2EqQYZR#NationalDonorDay
People with cystic fibrosis in Northern Ireland will get access #LifeSavingDrugsNow with deal on its way to fund Orkambi and Symkevi. More details as we get them.
Vertex selected 2 potential next-generation CFTR modulators, VX-659 and VX-445, to advance to Phase 3 clinical trials – an important next step in bringing modulator treatments to about 90% of people with #cysticfibrosis. on.cff.org/2Epemnj#CFresearch
We’re thrilled to announce one of our new Impact Grant recipients: Terry Wright, founder of Raising Cystic Fibrosis Engagement in the African American Community.
Thanks to advances in research and care, the proportion of adults with cystic fibrosis — at 62% — has surpassed that of children. While we’re encouraged by these trends, there is more to be done to meet the changing needs of the CF community.
“Three patients were safely dosed with 4D-710 gene therapy, and lung samples obtained show the first promising evidence of CFTR trans-gene expression in the lung. These are early safety data, but this is a milestone for CF.” - Deepika Polineni, MD, MPH #NACFC
Vertex announced that the @US_FDA has accepted application of Trikafta expansion to include children ages 6-11 years old with #cysticfibrosis who have certain mutations. The FDA has said it will make a decision by June 8, 2021. on.cff.org/3ol36h2
When the Foundation was established in 1955, people with #cysticfibrosis weren't expected to live to attend kindergarten. Today, people with CF are living into their 30s, 40s, and beyond, and achieving milestones of all kinds. #CFawareness
Today, Vertex released positive Phase 3 clinical trial data for VX-659, one of two next-generation, triple combination #cysticfibrosis modulators currently being tested. #CFresearchon.cff.org/2PUp0eV
"Being Black with cystic fibrosis means being misunderstood. It means being left out because approximately 5 percent of people with CF are Black. It means being an afterthought." on.cff.org/3fqC9oD
Vertex announced it has submitted three supplemental New Drug Applications to the @US_FDA to expand eligibility for Trikafta, Symdeko, and Kalydeco to additional rare CFTR mutations. on.cff.org/3jt4ooi
Help us support @Browns nominee for the Walter Payton NFL Man of the Year, @God_Son80! The nominee with the most hashtag mentions will receive a $25,000 contribution to their charity of choice.
Every RT is a vote! #WPMOYChallenge + Landry
The Foundation has awarded up to $1.61 million to Eloxx Pharmaceuticals Inc. to conduct an early Phase 2 clinical trial of an investigational drug that could potentially treat people with #cysticfibrosis who have a nonsense mutation. #CFresearchon.cff.org/2l1JJ29
We did it! 👏 Congress passed a spending bill that increases funding for the @US_FDA and @NIH, sending it to the president’s desk. Thank you to everyone in the #cysticfibrosis community who spoke out to support these agencies that are critical in the fight against CF. #CFadvocacy
When the CF Foundation was established in 1955, there were no treatments for cystic fibrosis. Today, there are more than a dozen new treatments for CF. #CFAwareness
That’s a wrap on #NACFC 2019! Thank you to everyone for following along. You are making a difference for all people living with #cysticfibrosis. #CFresearch
Good news for the #cysticfibrosis community: @US_FDA approved ivacaftor (Kalydeco) for children ages 1 to 2 in the U.S. who have at least one mutation that is responsive to ivacaftor. #CFresearchon.cff.org/2PddLtZ
Last night, Congress voted to fund #CHIP for the next 6 years. CHIP is vital for children with #cysticfibrosis and we are thankful that they will maintain access to the specialized care and treatments they need. #CFadvocacy
We’re thrilled to announce that KC White has been elected by the Foundation’s Board of Trustees as its next Board Chair. This marks the first time in our history that the Board will be led by a person with #cysticfibrosis. on.cff.org/KC-White-Next-Cha…
People with #cysticfibrosis are living longer than ever before and achieving dreams of all kinds. But we won’t stop until there’s a cure for CF.
Your involvement is critical to our progress. Give today and help make dreams come true: on.cff.org/give
What an exciting day for the #cysticfibrosis community! Congratulations and thank you to the @cftrust for their tireless fight for access to the triple-combination therapy.
Two years ago today, Trikafta®, a highly effective CFTR modulator, was approved by the @US_FDA. Since then, many in the cystic fibrosis community have seen transformative changes to their quality of life.
.@US_FDA has approved ivacaftor (Kalydeco) for babies as young as 6 months who have 1 of 38 CF mutations. The growing data on early treatment continues to support our belief that starting on modulators at a young age could help slow the progression of CF. on.cff.org/2vvYjAu
Cystic fibrosis affects more than just the lungs.
CF can cause changes in many parts of the body, including the lungs, pancreas, liver, intestines, sinuses, reproductive system, and sweat glands. #CFAwareness